Skip to main content

Perceptive Advisors LLC

SEC CIK
0001224962
Latest filing
Aug 14, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by Perceptive Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings

Shares (Q2 2026)
219,813
Value
$4.06M
% of portfolio
0.1%
Quarters held
6
Since Q1 2025
Holdings of AVTX by Perceptive Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026219,813$4.06M0.1%+80,146+57.4%AddedHolders
Q1 2026139,667$2.09M<0.1%00.0%UnchangedHolders
Q4 2025139,667$2.54M<0.1%00.0%UnchangedHolders
Q3 2025139,667$1.78M0.1%00.0%UnchangedHolders
Q2 2025139,667$696.9K<0.1%−380,333−73.1%ReducedHolders
Q1 2025520,000$4.17M0.1%+520,000NewHolders